NEW $70,000-$110,000USED $25,000-$45,000FDA Cleared 2015
Last updated: 2026-04-09
Overview
SculpSure is Cynosure (Hologic)'s entry in the body contouring category, built on 1060nm Diode Laser Lipolysis. The platform treats abdomen, flanks, thighs, back, submental (double chin), with 25 minutes per treatment and a recommended course of 1-2 sessions per area. FDA cleared in 2015, it lists in the $70,000-$110,000 range for new units and $25,000-$45,000 on the secondary market.
24% average fat reduction in treated area after a single 25-minute treatment. Hands-free applicators let one operator treat multiple areas simultaneously. The mechanism is what separates SculpSure from competitors in the same category. Where it fits in your practice depends on patient demographics, treatment volume, and whether you need a flagship platform or a value-tier alternative.
SculpSure is manufactured by Cynosure (Hologic) (Westford, MA, founded 1991). The device benefits from Cynosure (Hologic)'s public market visibility and presence across 130+ countries. Service support, training availability, and parts access vary by region. Practices considering this device should validate dealer presence and technical support coverage in their area before signing a contract.
20+ published studies. FDA clearance supported by multi-center trials showing 24% average fat layer reduction at 12 weeks. The published evidence base for SculpSure reflects how long the platform has been in market and how much the manufacturer has invested in clinical research. Devices with FDA clearance dates before 2018 typically have stronger peer-reviewed datasets than newer entrants. For physicians evaluating this device, the questions worth asking are whether the studies used blinded evaluators, what the sample sizes were, and whether the research was independent or manufacturer-funded.
Compare SculpSure's evidence base against the category benchmark. In SculpSure's category, the strongest evidence typically comes from devices that have been on the market for at least five years and have multiple randomized controlled trials with independent funding. Marketing claims from any manufacturer should be cross-checked against PubMed-indexed publications rather than conference posters or white papers. Conference presentations are not equivalent to peer review.
For practices that require strong clinical evidence (academic dermatology, plastic surgery groups with research interests, multi-physician practices that need to defend purchase decisions internally), the evidence profile should be a top-three decision factor. For high-volume cash-pay practices where patient demand drives device selection, brand recognition often matters more than the underlying evidence base. Both approaches are defensible, but they lead to different device selections.
ROI Analysis
Practice ROI for SculpSure depends on three variables: capital cost, per-session revenue, and treatment volume. At a new unit price of $70,000-$110,000, financed over five years at typical equipment rates, the monthly payment runs roughly 2-2.5% of total cost. Per-session revenue at $1,200-$1,800 means the device needs to fill enough treatment slots monthly to cover the payment, consumables ($500-$1,500), maintenance ($2,500-$6,000), and operator labor.
For a practice doing 2-3 treatments per day at the midpoint of the per-session range, SculpSure typically reaches break-even at 12-18 months for the lower end of the new pricing range, or 18-30 months at the high end. Used and refurbished units in the $25,000-$45,000 range can cut payback periods in half. The biggest practice mistake is over-projecting treatment volume. Physicians who run their numbers on 4-6 daily treatments rarely hit those targets in year one.
The realistic question is not whether SculpSure can pay back. Most devices in this price range do, eventually. The question is whether your practice can fill the schedule. Practices with existing patient flow in Dermatology, Plastic Surgery have the easiest path. Practices building demand from scratch should plan for 6-12 months of marketing investment before the device pays for itself.
Best For
Practices wanting a laser-based alternative to cryolipolysis with lower consumable costs. Med spas that want hands-free multi-area capability without adding operator labor. The fit is strongest for practices that match the device's positioning on price, clinical evidence requirements, and patient throughput expectations. Practices with mismatched economics often regret these purchases within 18 months.
Beyond practice type, SculpSure fits best when the patient base aligns with the device's strengths. For body contouring platforms, this usually means matching device capability to patient demographics, skin type range, and willingness to pay per-session pricing. Practices in markets where patients price-shop heavily need to factor that into device selection. Practices in concierge or luxury markets can charge premium pricing that justifies premium platforms.
Buying Guide
New SculpSure units sell for $70,000-$110,000 from Cynosure (Hologic) or authorized dealers. Refurbished and used units sell for $25,000-$45,000 on the secondary market. The decision between new and used comes down to warranty coverage, software version, included applicators, and consumable allowances. New units typically include a 12-24 month warranty, current software, all applicators, and a starter consumable package. Used units usually carry no warranty, may have outdated software, and require separate consumable purchases.
What to negotiate: applicator quantity (always ask for additional applicators thrown in), consumable starter packs, training and certification fees, extended warranty coverage, marketing materials, and clinical training for additional providers. Cynosure (Hologic) sales reps typically have 10-15% list price flexibility and far more on bundled deals. End-of-quarter and end-of-year are the strongest negotiation windows. Trade-in programs for older devices can reduce net cost by another 10-20%.
What to watch for: software lock-out fees on used units (some manufacturers disable software on resold devices), per-pulse or per-treatment licensing fees that show up after purchase, consumable price increases over the device life, and service contract terms. Always require a written quote that breaks out hardware, applicators, training, first-year service, and consumables separately. Bundled quotes hide the line items where margins live.
Alternatives and Comparisons
The main alternatives to SculpSure in this category are listed below. Click into any comparison for a full side-by-side breakdown.
CoolSculpting Elite: Established practices with existing Allergan relationships and patient demand for the CoolSculpting brand. Practices in markets where brand recognition drives v
Emsculpt Neo: Practices wanting the most versatile body contouring platform with both aesthetic and medical applications. High-volume med spas that can fill treatment slots.
truSculpt iD: Practices that want the fastest body contouring treatment with zero consumable costs. Med spas looking for a value-tier platform while the Cutera situation play
Vanquish ME: Value-conscious med spas wanting whole-abdomen treatment at a lower capital cost. Practices serving patients who want large treatment areas without applicator c
New SculpSure units sell for $70,000-$110,000 from Cynosure (Hologic) and authorized dealers. Used and refurbished units typically run $25,000-$45,000 on the secondary market depending on age, software version, and included applicators. Per-session pricing for treatments is $1,200-$1,800. Annual consumables run $500-$1,500 and annual maintenance averages $2,500-$6,000. Practices financing the device should expect monthly payments around 2-2.5% of the total purchase price over a five-year term.
Is SculpSure FDA cleared?
Yes. SculpSure received FDA 510(k) clearance in 2015. The clearance covers the indications listed in the device labeling. Off-label uses are common in clinical practice but should be discussed with patients explicitly. Physicians should verify current clearance status and any updates directly with Cynosure (Hologic) or via the FDA 510(k) database before making a purchase decision.
What is the clinical evidence behind SculpSure?
20+ published studies. FDA clearance supported by multi-center trials showing 24% average fat layer reduction at 12 weeks. When evaluating clinical evidence, look for blinded evaluator studies, independent funding sources, and peer-reviewed publications rather than manufacturer-funded white papers or conference posters. Evidence quality varies widely between devices in the same category, even when the marketing materials look similar.
Which specialties use SculpSure?
SculpSure is primarily used by Dermatology, Plastic Surgery, Med Spa, OB/GYN. Best fit varies by patient mix and practice economics. Practices wanting a laser-based alternative to cryolipolysis with lower consumable costs. Med spas that want hands-free multi-area capability without adding operator labor.
How long does a SculpSure treatment session take?
Each SculpSure treatment session runs 25 minutes per treatment. The recommended protocol is 1-2 sessions per area. Total chair time including consultation, setup, treatment, and post-treatment care is typically 1.5-2x the listed treatment time. Practices planning daily treatment volume should use the realistic chair-time number, not just the active treatment minutes.
What are the main pros and cons of SculpSure?
Strengths: Hands-free applicators allow multi-area treatment in one session; 25-minute treatment is among the fastest in the category; Low consumable costs compared to CoolSculpting. Weaknesses: Softening demand as newer RF and HIFEM platforms capture attention; Cynosure parent (Hologic) divestiture rumors create support uncertainty; Resale values have fallen sharply on the secondary market. Every device in this category has tradeoffs. The right choice depends on which strengths matter most to your practice and which weaknesses you can tolerate.
What does SculpSure cost to operate annually?
Annual operating costs for SculpSure include consumables ($500-$1,500), maintenance and service ($2,500-$6,000), and operator labor. Practices doing high treatment volumes should also budget for additional applicator wear and replacement. Total annual operating cost typically runs 5-15% of the original purchase price, with consumables driving most of the variability between low and high estimates.
Who manufactures SculpSure and how stable is the company?
SculpSure is manufactured by Cynosure (Hologic), headquartered in Westford, MA and founded in 1991. The company is publicly traded under ticker HOLX and operates in 130+ countries. Annual revenue is approximately Part of Hologic ($4B+). Manufacturer financial stability matters because it affects warranty support, parts availability, and long-term software updates. Physicians making capital purchases should always check the manufacturer's recent financial trajectory before committing.
Get Device Pulse every Tuesday
Weekly price tracker, FDA clearances, safety signals, and clinical evidence summaries. The only newsletter built for physicians who buy equipment.